Total Reports
12
FDA CVM filings
Dog /
FDA CVM · 2025 release 12 reports on file
Finnish Lapphund - FDA Adverse Event Profile
Adverse-event records for Finnish Lapphund (Dog) from the FDA Center for Veterinary Medicine.
Data updated June 2026
The record at a glance
Finnish Lapphund's FDA record: #419 most-reported dog breed, 12 total reports, 0.0% death-coded (0 reports).
- #419
- most-reported dog breed
- 0.0%
- death-coded report share
- 2
- Lethargy (see also Central nervous system depression in 'Neurological') - top reaction
- 5.8 yr
- average age at report
Read report counts next to breed popularity: a bigger number often just means more owners and more vet visits.
Deaths Reported
0
of 12 reports
Death Rate
0.0%
death-coded share
Avg Age at Report
5.8 yr
22.0 kg avg weight
Death-Coded Outcome Share
Finnish Lapphund death-coded reports 0.0%
Cross-breed median
0.0% of 12 finnish lapphund reports involved a death outcome.
How to read this number
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 22.0 kg (48.5 lbs)
Top Reported Reactions
Lethargy (see also Central nervous system depression in 'Neurological') 2
Lack of efficacy (endoparasite) - hookworm 2
Vomiting 2
Appetite loss 1
Loose stool 1
Most Referenced Drugs
Milbemycin Oxime + Spinosad 3
Ivermectin + Pyrantel As Pamoate Salt 3
Pyrantel Pamoate;Sarolaner 2
Sarolaner 1
Oclacitinib Maleate 1
Outcome Breakdown
Ongoing
5 (41.7%)
Recovered/Normal
4 (33.3%)
Outcome Unknown
2 (16.7%)
Recovered with Sequela
1 (8.3%)
Gender Distribution
Male 6 (50.0%)
Female 6 (50.0%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2013 | 1 | |
| 2014 | 1 | |
| 2017 | 2 | |
| 2019 | 2 | |
| 2021 | 1 | |
| 2022 | 1 | |
| 2024 | 1 | |
| 2025 | 3 | |
Finnish Lapphund Pet Health Insights
Finnish Lapphund accounts for 12 FDA adverse event reports, ranking #419 by volume among dog breeds, with 0 reports (0.0%) coded as a death outcome. Mean age at report: 5.8 years, average weight 22.0 kg (48.5 lbs).
Top reported signs: Lethargy (see also Central nervous system depression in 'Neurological') (2), Lack of efficacy (endoparasite) - hookworm (2), Vomiting (2). Most-referenced drug: Milbemycin Oxime + Spinosad (3 reports), followed by Ivermectin + Pyrantel As Pamoate Salt (3) and Pyrantel Pamoate;Sarolaner (2).
Outcome coding on 12 status-recorded reports is dominated by Ongoing (41.7%). Annual submissions ranged 2,013-2,025 across 8 years on file.
Dog Breeds With a Similar Report Volume
Frequently Asked Questions
How many FDA adverse event reports involve Finnish Lapphund? ▼
There are 12 adverse event reports involving Finnish Lapphund in the FDA database, with 0 reports involving death (0.0% death rate). Finnish Lapphund ranks #419 by report volume.
What are the most common adverse reactions reported for Finnish Lapphund? ▼
The most commonly reported adverse reactions for Finnish Lapphund are Lethargy (see also Central nervous system depression in 'Neurological') (2 reports), Lack of efficacy (endoparasite) - hookworm (2 reports), Vomiting (2 reports), Appetite loss (1 reports), Loose stool (1 reports).
What drugs are most frequently associated with Finnish Lapphund adverse events? ▼
The drugs most frequently referenced in Finnish Lapphund adverse event reports are Milbemycin Oxime + Spinosad (3 reports), Ivermectin + Pyrantel As Pamoate Salt (3 reports), Pyrantel Pamoate;Sarolaner (2 reports), Sarolaner (1 reports), Oclacitinib Maleate (1 reports).
What is the average age of Finnish Lapphund in adverse event reports? ▼
The average age of Finnish Lapphund at the time of adverse event reports is 5.8 years, with an average weight of 22.0 kg (48.5 lbs).
Does a high number of adverse event reports mean Finnish Lapphund is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Finnish Lapphund safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how death rate and rankings are computed.
Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.